184 related articles for article (PubMed ID: 14529932)
1. Limited utility of cyclosporine C2 monitoring in heart transplant recipients receiving ketoconazole.
Zakliczynski M; Krynicka A; Szewczyk M; Wojarski J; Zembala M
Transplant Proc; 2003 Sep; 35(6):2333-4. PubMed ID: 14529932
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of therapeutic monitoring of cyclosporine through C2 and AUC(0-4) during the first 24 months following kidney transplantation].
Vavić N; Ignjatović L; Drasković B; Hrvacević R; Kovacević Z; Paunić Z
Vojnosanit Pregl; 2008 Feb; 65(2):119-27. PubMed ID: 18365668
[TBL] [Abstract][Full Text] [Related]
3. C2 and C0 values for monitoring cyclosporine therapy in stable heart transplant recipients.
Diciolla F; Scolletta S; Berti L; Maccherini M; Federici D; Bernazzali S; Lisi G; Chiavarelli M
Transplant Proc; 2005 Mar; 37(2):1355-9. PubMed ID: 15848719
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine monitoring with 2-hour postdose levels in heart transplant recipients.
Solari SG; Goldberg LR; DeNofrio D; Shaw LM
Ther Drug Monit; 2005 Aug; 27(4):417-21. PubMed ID: 16044096
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine C2 monitoring is superior to C0 in predicting acute cellular rejection in heart transplant recipients in Taiwan.
Chou NK; Chen RJ; Ko WJ; Lin HL; Yu SY; Chen YS; Hsu RB; Lee CM; Lin FY; Wang SS
Transplant Proc; 2004 Oct; 36(8):2393-5. PubMed ID: 15561260
[TBL] [Abstract][Full Text] [Related]
6. New strategies of cyclosporine monitoring in heart transplantation: initial results.
Arizón del Prado JM; Aumente Rubio MD; Cárdenas Aranzana M; López Malo de Molina MD; Segura Saint-Gerons J; López Granados A; Rodríguez Esteban E; Ruiz Ortiz M; Romo Peñas E; Muñoz Carvajal I; González Rodríguez JR; Segura Saint-Gerons C; Vallés Belsué F; Concha Ruiz M
Transplant Proc; 2003 Aug; 35(5):1984-7. PubMed ID: 12962870
[TBL] [Abstract][Full Text] [Related]
7. Evolution of the therapeutic drug monitoring of cyclosporine.
Citterio F
Transplant Proc; 2004 Mar; 36(2 Suppl):420S-425S. PubMed ID: 15041378
[TBL] [Abstract][Full Text] [Related]
8. Correlations between cyclosporine concentrations at 2 hours post-dose and trough levels with functional outcomes in de novo lung transplant recipients.
Maziers N; Bulpa P; Jamart J; Delaunois L; Eucher P; Evrard P
Transplant Proc; 2012 Nov; 44(9):2880-4. PubMed ID: 23146546
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of cyclosporine 2-hour post-dose levels in heart transplantation: improvement in clinical outcomes.
Delgado DH; Rao V; Hamel J; Miriuka S; Cusimano RJ; Ross HJ
J Heart Lung Transplant; 2005 Sep; 24(9):1343-6. PubMed ID: 16143255
[TBL] [Abstract][Full Text] [Related]
10. Ketoconazole alters cyclosporine pharmacokinetic profile and may predispose to acute rejection.
Dominguez J; Kompatzki A; Foradori A; Norambuena R
Transplant Proc; 2003 Nov; 35(7):2522-3. PubMed ID: 14612002
[TBL] [Abstract][Full Text] [Related]
11. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients.
Paydaş S; Balal M; Sertdemir Y; Seyrek N; Karayaylali I
Ren Fail; 2005; 27(4):409-13. PubMed ID: 16060128
[TBL] [Abstract][Full Text] [Related]
12. Dose adjustment strategy of cyclosporine A in renal transplant patients: evaluation of anthropometric parameters for dose adjustment and C0 vs. C2 monitoring in Japan, 2001-2010.
Kokuhu T; Fukushima K; Ushigome H; Yoshimura N; Sugioka N
Int J Med Sci; 2013; 10(12):1665-73. PubMed ID: 24151438
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine C0- versus C2-monitoring over three years in maintenance heart transplantation.
Hermann M; Enseleit F; Fisler AE; Flammer A; Lüscher TF; Noll G; Ruschitzka F
Swiss Med Wkly; 2011; 141():w13149. PubMed ID: 21293979
[TBL] [Abstract][Full Text] [Related]
14. Assessment of cyclosporine pharmacokinetic parameters to facilitate conversion from C0 to C2 monitoring in heart transplant recipients.
Davies RA; Veinot JP; Williams K; Haddad H; Baker A; Donaldson J; Pugliese C; Struthers C; Masters RG; Hendry PJ; Mesana T
Transplant Proc; 2007 Dec; 39(10):3334-9. PubMed ID: 18089382
[TBL] [Abstract][Full Text] [Related]
15. C2 is an age-independent parameter for optimal cyclosporine exposure in long-term kidney transplant recipients.
Ferraresso M; Citterio F; Ghio L; Romagnoli J; Edefonti A; Berardinelli L; Castagneto M
Transplant Proc; 2004 Nov; 36(9):2656-8. PubMed ID: 15621115
[TBL] [Abstract][Full Text] [Related]
16. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
17. Clinical benefit of neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients.
Cantarovich M; Elstein E; de Varennes B; Barkun JS
Transplantation; 1999 Dec; 68(12):1839-42. PubMed ID: 10628760
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine profiling with C2 and C0 monitoring improves outcomes after heart transplantation.
Barnard JB; Thekkudan J; Richardson S; Bittar MN; Martyszczuck R; Hasan J; Khasati N; Keevil B; Yonan N
J Heart Lung Transplant; 2006 May; 25(5):564-8. PubMed ID: 16678036
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine C2 monitoring improves renal dysfunction after lung transplantation.
Glanville AR; Morton JM; Aboyoun CL; Plit ML; Malouf MA
J Heart Lung Transplant; 2004 Oct; 23(10):1170-4. PubMed ID: 15477111
[TBL] [Abstract][Full Text] [Related]
20. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
